Potassium Iodide Tablets USP 130mg
Product Details:
- Drug Type General Medicines
- Physical Form Tablets
- Recommended For human being
- Dosage 130 mg
- Dosage Guidelines as per suggection
- Click to View more
X
Potassium Iodide Tablets USP 130mg Price And Quantity
- 50 Box
Potassium Iodide Tablets USP 130mg Product Specifications
- as per suggection
- 130 mg
- human being
- Tablets
- General Medicines
Potassium Iodide Tablets USP 130mg Trade Information
- 5000 Box Per Month
- 7 - 10 Days
- All India
Product Description
130 MG Potassium Iodide Tablets USP are recommended for human beings who require a dosage of 130 mg of potassium iodide. These tablets are available in a physical form and fall under the category of general medicines. The dosage guidelines for these tablets should be followed as per the suggestion of a healthcare professional. As an exporter, manufacturer, and supplier, we ensure the quality and effectiveness of these tablets for the intended use.
FAQs of 130 MG Potassium Iodide Tablets USP:
Q: What is the recommended dosage for these tablets?
A: The recommended dosage for these tablets is 130 mg.Q: What form do these tablets come in?
A: These tablets come in a physical form.Q: Who are these tablets recommended for?
A: These tablets are recommended for human beings.Q: What is the drug type of these tablets?
A: These tablets fall under the category of general medicines.Q: What are the dosage guidelines for these tablets?
A: The dosage guidelines for these tablets should be followed as per the suggestion of a healthcare professional.Enter Buying Requirement Details
Other Products in 'Pharmaceutical Tablets' category
SANKALP HEALTHCARE AND ALLIED PRODUCTS PVT LTD
GST : 27AAFCS8395A1Z5
GST : 27AAFCS8395A1Z5
1st Floor, Shriram Building, Near Satyam Industrial Estate, Station Road, Govandi East,Mumbai - 400088, Maharashtra, India
Phone :07317186543
Send Inquiry
|
 |
SANKALP HEALTHCARE AND ALLIED PRODUCTS PVT LTD
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |